器官保存解决方案市场概览、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPHE100001100
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 196
Buy Now

Organ Preservation Solution Market Forecast, Scope by 2031

Buy Now

器官保存液市场规模预计将从 2023 年的 2.7441 亿美元增至 2031 年的 5.1262 亿美元。预计 2023-2031 年期间市场复合年增长率将达到 8.2%。向机器灌注技术的转变可能仍是市场的主要趋势。

器官保存解决方案市场分析

器官保存液是一种专用液体,用于在移植过程中保存肾脏、心脏、肝脏和胰腺等器官。器官移植是终末期器官衰竭患者的唯一治疗选择。慢性病患病率的不断上升和器官移植需求的不断增加是器官保存液市场发展的有利因素。

器官保存解决方案市场概况

2023 年,加拿大卫生信息研究所 (CIHI) 报告称,该国进行了 3,428 例器官移植手术。在这些移植手术中,83% 使用了已故捐赠者的器官,17% 使用了活体捐赠者的器官。因此,器官移植手术数量的增加为器官保存解决方案市场带来了增长前景。各国政府正在与市场参与者合作,以了解灌注系统,从而改善健康。例如,中国已在其医院安装了 XVIVO 灌注系统,该公司也在寻求 CFDA 的批准。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

器官保存解决方案市场:

器官保存解决方案市场
  • Organ Preservation Solution Market
    复合年增长率(2023 - 2031)
    8.2%
  • 2023 年市场规模
    2.7441 亿美元
  • 市场规模 2031
    5.1262 亿美元

市场动态

增长动力
  • 器官移植需求不断增长
未来趋势
  • 转向机器灌注技术
机会
  • 市场参与者的战略举措

关键人物

  • 沃特世医疗系统有限公司,
  • XVIVO 灌注,
  • TransMedics,
  • OrganOx 有限公司,
  • Paragonix Technologies, Inc.
  • Franz Koehler Chemie GmbH 博士,
  • 雅阁医疗,
  • 圣世纪医药
  • 上海健新医药科技有限公司
  • 生命之桥有限公司

区域概况

Organ Preservation Solution Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Organ Preservation Solution Market类型
  • 威斯康星大学解决方案
  • 卡斯托迪奥HTK
  • 帕法得克斯
  • 低温土壤
Organ Preservation Solution Market应用
  • 静态冷藏
  • 低温灌注机
  • 常温机灌注
Organ Preservation Solution Market器官类型
  • 肾脏
Organ Preservation Solution Market最终用户
  • 器官移植中心
  • 医院
  • 专科诊所
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

器官保存解决方案市场驱动因素和机遇

慢性病患病率上升利好市场

慢性肾病 (CKD) 是一种常见且可能致命的疾病,全球约有十分之一的人患有此病。美国国家肾脏基金会 (National Kidney Foundation) 于 2020 年发布的一项研究预测,20 岁以上的糖尿病患者中约有 35.0% 会随着时间的推移患上慢性肾病。根据美国卫生资源和服务管理局 (HRSA) 的数据,截至 2022 年,约有 88,901 名患者在肾脏等候名单上。每天,有近 21 人在等待器官移植时死亡,而超过 120,000 名男性、女性和儿童寻求挽救生命的器官移植手术。慢性疾病可能是先天性的,也可能是后天性的,会随着时间的推移导致器官逐渐受损。慢性疾病通常不会自行解决,但可能有办法减缓或减轻疾病造成的损害。这种损害可能需要数十年才能积累到明显影响患者器官功能或需要医疗干预的程度。慢性心脏病,包括冠状动脉疾病和先天性心脏病,可导致进行性心力衰竭。因此,慢性病的患病率不断上升,增加了器官移植过程中对器官保存解决方案的需求。

市场参与者战略举措不断涌现,创造市场机遇

各市场参与者专注于产品发布或战略合作,以开发有助于缓解慢性疾病治疗的先进产品。近年来,出现了各种发展,例如产品发布、合并和收购。

  • 2023 年 11 月,Paragonix Technologies 推出了全面的捐献器官采购、保存和运输服务网络。此次扩张包括在美国各地建立七个战略位置的采购中心,旨在优化移植界的协调和物流。这些支持中心全天候开放,由一支由 50 多名杰出采购专业人员组成的团队组成,其中包括经过认证的外科医生和保存专家,他们都致力于推进器官移植。
  • 2022 年 4 月,TransMedics Group, Inc. 的 OCS 心脏系统获得 FDA 上市前批准,可用于循环死亡后从捐献者身上获取的器官。OCS 心脏系统获得批准,其临床适应症扩展为体外复活、功能监测和循环死亡后 (DCD) 捐献者心脏的跳动保存。

因此,产品审批、上市和战略合作的激增可能会为未来器官保存解决方案市场创造相当大的增长机会。

器官保存解决方案市场报告细分分析

有助于得出器官保存解决方案市场分析的关键部分是产品、类型、应用和最终用户。

  • 根据产品,器官保存溶液市场细分为威斯康星大学溶液、Custodiol HTK、Perfadex、Hypothermosol 和其他。威斯康星大学溶液部门在 2023 年占据了最大的市场份额。
  • 根据器官类型,市场分为肾脏、肝脏、肺、心脏和其他。肾脏部分在 2023 年占据了最大的市场份额。
  • 根据应用,市场分为静态冷藏、低温机器灌注、常温机器灌注和其他。静态冷藏部分在 2023 年占据了最大的市场份额。
  • 根据最终用户,市场分为器官移植中心、医院和专科诊所。器官移植中心部分在 2023 年占据市场主导地位。

器官保存解决方案市场份额(按地区)分析

器官保存解决方案市场报告的地理范围主要分为五个区域:北美、亚太地区、欧洲、中东和非洲以及南美和中美洲。2023 年,北美占据了市场主导地位。北美器官保存解决方案市场已在美国、加拿大和墨西哥的基础上进行了分析。越来越多地采用技术先进的产品和解决方案,以及器官移植数量的激增是该地区器官保存解决方案市场受益的因素。2023 年,美国占据北美器官保存解决方案市场的最大份额。2024 年 6 月,美国肾脏基金会报告称,多达 3700 万美国人患有肾脏疾病,约 808,000 名美国人患有肾衰竭。超过 557,000 名美国人正在接受透析治疗。肾脏疾病的患病率正在上升,目前影响超过七分之一(或 14%)的美国成年人。

美国食品药品管理局 (FDA) 批准数量的增加以及市场参与者的存在进一步推动了美国器官保存解决方案市场的增长。2022 年 4 月,TransMedics Group, Inc. 宣布其 OCS 心脏系统已获得 FDA 上市前批准,该系统可用于循环死亡 (DCD) 后捐赠者的器官。OCS 心脏系统被批准用于体外复活、功能监测和循环死亡后 (DCD) 捐赠心脏的跳动保存。

器官保存解决方案市场报告范围

报告属性细节
2023 年的市场规模2.7441亿美元
2031 年市场规模5.1262亿美元
全球复合年增长率(2023 - 2031)8.2%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 威斯康星大学解决方案
  • 卡斯托迪奥HTK
  • 帕法得克斯
  • 低温土壤
按应用
  • 静态冷藏
  • 低温灌注机
  • 常温机灌注
按器官类型
  • 肾脏
按最终用户
  • 器官移植中心
  • 医院
  • 专科诊所
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 沃特世医疗系统有限公司,
  • XVIVO 灌注,
  • TransMedics,
  • OrganOx 有限公司,
  • Paragonix Technologies, Inc.
  • Franz Koehler Chemie GmbH 博士,
  • 雅阁医疗,
  • 圣世纪医药
  • 上海健新医药科技有限公司
  • 生命之桥有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

器官保存解决方案市场新闻和最新发展

器官保存解决方案市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。器官保存解决方案市场的一些发展如下所列:

  • Bridge to Life 已将 EasiSlush 重新引入美国市场,满足了对用于器官移植的易于使用的无菌泥浆的高需求。EasiSlush 以其易用、高品质和便携性而闻名,使其成为器官移植专业人士的首选。(来源:Bridge to Life,公司网站,2024 年 2 月)
  • OrganOx 与生物技术公司 Ochre Bio 合作,后者开发用于治疗慢性肝病的 RNA 药物。作为合作的一部分,OrganOx 向 Ochre Bio 及其合作伙伴提供 metra 设备,用于评估使用废弃捐赠肝脏的新型 RNA 疗法。(来源:OrganOx,公司网站,2024 年 3 月)

器官保存解决方案市场报告覆盖范围和交付成果

“器官保存解决方案市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 器官保存解决方案市场规模及全球、区域和国家层面所有关键细分市场的预测
  • 器官保存解决方案市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 器官保存解决方案市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及器官保存解决方案市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the organ preservation solutions market?

The organ preservation solutions market majorly consists of the players, including Waters Medical Systems LLC, XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, ST CENTURY MEDICINE, Shanghai Genext Pharmaceutical Technology, and Bridge to Life Ltd.

What was the estimated organ preservation solutions market size in 2023?

The organ preservation solutions market was valued at US$ 274.41 million in 2023.

What are the growth estimates for the organ preservation solutions market till 2031?

The organ preservation solutions market is expected to be valued at US$ 512.62 million by 2031.

Which product segment dominates the organ preservation solutions market?

The organ preservation solutions market, by product, is segmented into University of Wisconsin Solution, Custodiol HTK, Perfadex, Hypothermosol, and Others. The University of Wisconsin Solution segment held the largest organ preservation solution market share in 2023.

What are the driving and restraining factors for the organ preservation solutions market?

The factors driving the growth of the organ preservation solutions market include the increasing prevalence of chronic diseases and the rising need for organ transplantation. However, the expensive organ transplant surgeries and limited organ availability hampers the growth of the Organ preservation solutions market.

What is organ preservation solutions?

Organ preservation solution is a specialized fluid used to preserve organs such as kidney, heart, liver, and pancreas outside the body during transplantation. Organ transplantation is the only treatment option for patients with end-stage organ failure.

The List of Companies - Organ Preservation Solution Market

  1. Waters Medical Systems LLC
  2. XVIVO Perfusion
  3. TransMedics
  4. OrganOx Limited
  5.  Paragonix Technologies, In,
  6. Dr. Franz Koehler Chemie GmbH
  7. Accord Healthcare
  8. ST CENTURY MEDICINE
  9. Shanghai Genext Pharmaceutical Technology,
  10. Bridge to Life Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..